BridgeBio Pharma, Inc. (BIT:1BBIO)
Italy · Delayed Price · Currency is EUR 65.98
+0.74 (1.13%)
At close: Jan 21, 2026
BridgeBio Pharma Revenue
BridgeBio Pharma had revenue of $120.70M USD in the quarter ending September 30, 2025, with 4,318.01% growth. This brings the company's revenue in the last twelve months to $353.78M, up 62.46% year-over-year. In the year 2024, BridgeBio Pharma had annual revenue of $221.90M with 2,285.27% growth.
Revenue (ttm)
$353.78M
Revenue Growth
+62.46%
P/S Ratio
42.70
Revenue / Employee
$484.63K
Employees
730
Market Cap
12.88B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 221.90M | 212.60M | 2,285.27% |
| Dec 31, 2023 | 9.30M | -68.35M | -88.02% |
| Dec 31, 2022 | 77.65M | 7.93M | 11.38% |
| Dec 31, 2021 | 69.72M | 61.47M | 745.14% |
| Dec 31, 2020 | 8.25M | -32.31M | -79.66% |
| Dec 31, 2019 | 40.56M | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Edison | 15.39B |
| Telecom Italia | 14.43B |
| Unipol Assicurazioni | 10.54B |
| Terna | 3.89B |
| Mediobanca Banca di Credito Finanziario | 3.32B |
| Moncler | 3.10B |
| Italgas | 3.05B |
| Recordati Industria Chimica e Farmaceutica | 2.55B |